Stem cell donor chokes back tears on first meeting with toddler whose life he saved – Mirror.co.uk
Mirror.co.uk |
Stem cell donor chokes back tears on first meeting with toddler whose life he saved
Mirror.co.uk Little Olly Walls giggles with joy as he’s lifted high into the air by the stranger who saved his life. But for stem cell donor Luke Munro and three-year old Olly’s parents, their first ever meeting was much more emotional. The lively toddler is … |
OncLive |
First Treatment Approved for Disease Linked to Stem Cell Transplant
U.S. News & World Report WEDNESDAY, March 30, 2016 (HealthDay News) — Defitelio (defibrotide sodium) has been approved by the U.S. Food and Drug Administration to treat a rare, but usually fatal liver disease that affects some people who have had a stem cell transplant. FDA Approves Defibrotide for Hepatic VOD Following Stem Cell TransplantationOncLive FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrowFDA.gov |
Daily Mail |
First ever human stem cell trials to replace those damaged by Parkinson’s
Daily Mail A cure for Parkinson’s disease could be on the horizon after a research team was given permission to start the first ever human stem–cell trials. Parkinson’s is a progressive neurological condition that destroys the brain cells producing the chemical … Scientists regenerate spinal cord in injured rats with stem cellsArs Technica VIDEO: Faculty Hires in Adult and Induced Pluripotent Stem Cell Research to Advance Interdisciplinary Pursuit of …ND Newswire New stem cell-based therapies for Parkinson’s Disease may be on the horizonNews-Medical.net Medical News Today –The Australian Financial Review –Next Big Future all 23 news articles » |
OncLive |
FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
FDA.gov The U.S. Food and Drug Administration today approved Defitelio (defibrotide sodium) to treat adults and children who develop hepatic veno-occlusive disease (VOD) with additional kidney or lung abnormalities after they receive a stem cell transplant … First Treatment Approved for Disease Linked to Stem Cell TransplantU.S. News & World Report FDA Approves Defibrotide for Hepatic VOD Following Stem Cell TransplantationOncLive FDA Says “Yes” to Defibrotide (Defitelio) for Hepatic Veno-Occlusive Disease Following Stem–Cell TransplantationManaged Care magazine The Pharma Letter (registration) all 50 news articles » |
U.S. News & World Report |
Italian scientist Dr. Paolo Macchiarini was once considered a pioneer in regenerative medicine
U.S. News & World Report Italian scientist Dr. Paolo Macchiarini was once considered a pioneer in regenerative medicine, credited with creating the world’s first windpipe partially made from a patient’s own stem cells. But in the last year, Macchiarini has been embroiled in a … |